Navigation Links
Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
Date:11/14/2011

first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 3 clinical development for both refractory advanced colorectal cancer and multiple myeloma, and in Phase 1 and 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 studies is being conducted under a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to an SPA agreement with the FDA. Keryx is headquartered in New York City.

Cautionary Statement
Some of the statements included in this press release, particularly those anticipating the outcome of clinical trials and the future business prospects for Zerenex (ferric citrate), may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully complete clinical trials for Zerenex; our ability to meet anticipated development timelines for Zerenex due to clinical trial results, manufacturing capabilities or other factors; our ability to replicate in our ongoing long-term Phase 3 clinical study the efficacy and safety of Zerenex observed in the previous Phase 2 studies and the short-te
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
3. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
4. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
5. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
7. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
8. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
9. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015  Agena Bioscience today announced Bioyong Technology as ... platform in China . "The ... a hotbed for practical, meaningful innovations that are improving human ... the rest of the world. We are proud to support ... ," said Peter Dansky , Agena Bioscience,s CEO. ...
(Date:4/27/2015)... , April 27, 2015  As the Innovation ... Philadelphia , InCrowd, provider of on-demand ... assembly of life science insights experts in charting a ... technology and innovation in research. Presented jointly ... supported by Communispace Health, IIeX Health features TED-style presentations ...
(Date:4/27/2015)... HANGZHOU, China , April 27, 2015 ... (the "Company" or " China Jo-Jo "), a leading ... health care products through its online and retail pharmacies, ... Co., Ltd. ("Jiuzhou Pharmacy") has signed a new sales ... wholly owned subsidiary in China ...
Breaking Medicine Technology:Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 2China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 3China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth Pharmaceutical, a Subsidiary of Pfizer 4
... 2007 /PRNewswire-FirstCall/ -,Neurochem (International) Limited (Neurochem), a ... the New England,Journal of Medicine (NEJM) published ... Trial" (EFAAT), recognized as a landmark,clinical trial ... AA amyloidosis. The,results of the Phase II/III ...
... Improves Cognition in two,distinct models of Alzheimer's ... - Prana Biotechnology,Limited (NASDAQ: PRAN / ASX: ... and development of treatments for,neurodegenerative disorders, announced ... Prana's lead Alzheimer's disease (AD) drug PBT2 ...
Cached Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5Prana Biotechnology Presents New Key Findings on PBT2 2Prana Biotechnology Presents New Key Findings on PBT2 3Prana Biotechnology Presents New Key Findings on PBT2 4Prana Biotechnology Presents New Key Findings on PBT2 5
(Date:4/27/2015)... 27, 2015 The Radiology Business ... members with applied business information and intelligence, is proud ... weekly email newsletter for its more than 2,000 members. ... care legislative news sources in that it is exclusively ... business of radiology. The newsletter is produced in cooperation ...
(Date:4/27/2015)... April 27, 2015 Cambia Health ... has joined its team as Operating Partner within ... focused on investing in and building companies that change ... his new role, Albert will be responsible for accelerating ... so that it is both economically sustainable and person-focused, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Health conscious ... have a first-of-its-kind bakery right on their doorstep, which ... for those on restrictive and low-carbohydrate diets. ... grain, and starch free, and will use only natural ... May 1, 2015, strives to provide specialty food that ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... With the FCPX LUT B&W pack from Pixel ... quickly and easily add desaturated color grades to footage. A ... for modifying an image. The LUT changes every pixel's color ... comes with 60 black and white CUBE LUT files. , ... white films. With the FCPX LUT B&W Loader from ...
Breaking Medicine News(10 mins):Health News:Radiology Business Management Association Launches Weekly Legislative and Policy Newsletter 2Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2
... Security Risks in Exotic Locales , ... Baltimore, MD ... in a down economy should prepare for unexpected medical and security ... vacation. Old and new destinations offering steep discounts may carry risks ...
... kick the habitOLYMPIA, Wash., March 31 A new federal ... cost of a pack of cigarettes by 62 cents. Public ... to quit smoking. The Department of Health,s toll-free Tobacco Quit ... expected loss in sales as more people quit smoking, several ...
... Conference , April 4 - 8 in ChicagoCHICAGO, March 31 ... leading Workforce Management consulting firm, has ... practice dedicated to the Workforce Management (WFM) needs of the ... HIMSS09 , the Healthcare Information and Management ...
... WASHINGTON, March 31 The following is being issued ... 1, at 12:00 noon, D.C. area Pro-life leaders and ... change in HHS regs regarding conscience for health care ... abortion or chemical birth control.A local physician will be ...
... COMPLAINT & ATTORNEY INTERVIEWS AVAILABLE -SEATTLE, March 31 ... tracheal tube clogged with mucous causing oxygen loss and ... Aldercrest Health & Rehabilitation Center in Edmonds, Wash., has ... States-based subsidiaries of Canadian Extendicare REIT. Norene McPherson,s 49-year-old ...
... testimony today before the U.S. Senate Committee on Agriculture, ... revise school food nutrition standards so that more nutritious ... federal nutrition standards for foods sold outside of the ... updated since the late 1970s. , ...
Cached Medicine News:Health News:Don't Sacrifice Your Well-being in a Discount Destination 2Health News:Don't Sacrifice Your Well-being in a Discount Destination 3Health News:Federal Tobacco Tax Increase a Good Reason to Quit Smoking 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 2Health News:Axsium Group Launches Workforce Management Practice for Healthcare Industry 3Health News:Elder Abuse Complaint Filed Against Extendicare 2Health News:Elder Abuse Complaint Filed Against Extendicare 3Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 2Health News:Mars Snackfood Urges U.S. Congress to Update National School Nutrition Standards 3
Small, compact and versatile, the CLK-4 light source is compatible with all Olympus fiberscopes and is ideal for the vast majority of routine fiber-endoscopic procedures, especially in the out-patien...
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The under-patient design of the pediatric full access blanket warms even the tiniest patients while allowing full access for surgeons and staff....
2-ply material consisting of polyethylene film inner layer and non-woven outer layers. Polyethylene cover....
Medicine Products: